This article was originally published in The Tan Sheet
Lactobacillus "is safe and effective as a treatment for infectious diarrhea in children," according to meta-analysis published in April Pediatrics. Cornelius Van Niel, MD, University of Washington, et al., found a significant .7 day reduction in diarrhea duration among subjects who were given Lactobacillus compared with placebo, and a reduction in diarrhea frequency of 1.6 stools on second day of treatment with the probiotic. Researchers did not find the effect was modified by country of study or live versus killed Lactobacillus preparation. Meta-analysis included nine randomized, controlled trials from 1973 to 2000 examining children up to three years old. Van Niel et al. suggest additional research should include a large, randomized trial funded by a non-vested party, use of consistent measures of diarrhea intensity...
You may also be interested in...
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.
Warning letters show FDA's coronavirus investigations inthe consumer health marketplace didn't stop when it suspended facility inspections. The letters identify firms that previously marketed only bedding products as offering supplements with coronavirus claims or that are in other countries and are shipping to US consumers products promoted with coronavirus claims.